The American Journal of Medicine
Volume 122, Issue 12 , Pages 1106-1114 , December 2009

The Obesity Paradox, Weight Loss, and Coronary Disease

References 

  1. American Obesity Association. AOA Fact Sheets: Obesity in the U.S.. Washington, DC: American Obesity Association; 2002;http://www.obesity.org/subs/fastfacts/obesity_US.shtmlAccessed April 2007
  2. Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol. 2003;42(4):677–679
  3. Lavie CJ, Milani RV. Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes. J Cardiopul Rehab. 2005;25:59–66
  4. Miller MT, Lavie CJ, White CJ. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr. 2008;3(3):162–167
  5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977
  6. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease—risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–1932
  7. Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  8. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure—the obesity paradox. Am J Cardiol. 2003;91:891–894
  9. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61
  10. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox of reverse epidemiology?. Eur Heart J. 2005;26:5–7
  11. Lavie CJ, Milani RV, Ventura HO, et al. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol. 2007;100:1460–1464
  12. Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–870
  13. Lavie CJ, Milani RV, Ventura HO. Obesity, heart disease, and favorable prognosis—truth or paradox?. Am J Med. 2007;120:825–826
  14. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–678
  15. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity?. Eur Heart J. 2007;28:2047–2048
  16. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J. 2007;28:2087–2093
  17. See R, Abdullah SM, McGuire DK, et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis. J Am Coll Cardiol. 2007;50:752–759
  18. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28:850–856
  19. Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J, Somers VK. Differentiating between body fat and lean mass how should we measure obesity?. Nat Clin Pract Endocrinol Metab. 2008;4(6):322–323
  20. Thomas RJ, King M, Lui K, et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services: endorsed by the American college of chest physicians, American college of sports medicine, American physical therapy association, Canadian association of cardiac rehabilitation, European association for cardiovascular prevention and rehabilitation, inter-American heart foundation, national association of clinical nurse specialists, preventive cardiovascular nurses association, and the society of thoracic surgeons. J Am Coll Cardiol. 2007;50:1400–1433
  21. Cortés O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review. Am Heart J. 2006;151:249–256
  22. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892–902
  23. Williams MA, Ades PA, Hamm LF, et al. Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J. 2006;152:835–841
  24. Lavie CJ, Milani RV. Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs. Am Heart J. 1994;128(6, pt 1):1105–1109
  25. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on low density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol. 1994;74:1192–1195
  26. Surgeon General's report on physical activity and health (From the Centers for Disease Control and Prevention). JAMA. 1996;276:522
  27. Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004;43:1056–1061
  28. Lucini D, Milani RV, Costantino G, et al. Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J. 2002;143:977–983
  29. Church TS, Lavie CJ, Kirby GS, Milani RV. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J. 2002;143(2):349–355
  30. Lavie CJ, Milani RV. Prevalence of hostility in young coronary patients and effects of cardiac rehabilitation and exercise training. Mayo Clin Proc. 2005;80:335–342
  31. Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvements following cardiac rehabilitation and exercise training. Am J Cardiol. 2004;93:336–339
  32. Lavie CJ, Milani RV. Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med. 2006;166:1878–1883
  33. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120:799–806
  34. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1998;260:945–950
  35. O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80(2):234–244
  36. Balady JG, McInnes KJ. Cardiac rehabilitation in obese patients. Chest. 1996;109:3–4
  37. Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol. 1997;79:397–401
  38. Lavie CJ, Milani RV. Exercise training in special populations: obesity. In:  Wenger NK,  Smith LK,  Froelicher ES,  Comoss PM editor. Cardiac Rehabilitation: A Guide to Practice in the 21st Century. New York: Marcel Dekker Inc; 1999;p. 151–154
  39. Fonarow GC, Horwich TB, Hamilton MA, et al. Obesity, weight reduction and survival in heart failure: reply. J Am Coll Cardiol. 2002;39:1563–1564
  40. Allison DB, Zannolli R, Faith MS, et al. Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23(6):603–611
  41. Physical status: the use and interpretation of anthropometry (Report of a WHO expert committee). World Health Organ Tech Rep Ser. 1995;854:1–452
  42. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea?. Circulation. 2004;110:e27–e31
  43. Milani RV, Lavie CJ, Merha MR, Ventura HO. Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006;81(12):1603–1611
  44. Jackson AS, Pollock ML. Practical assessment of body composition. Physician Sports Med. 1985;13:76–90
  45. Kellner R. A symptom questionnaire. J Clin Psychiatry. 1987;48:268–274
  46. Gustafsson F, Kragelund CB, Thorp-Pedersen C, et al. DIAMOND study group Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J. 2005;26:58–64
  47. Lavie CJ, Milani RV, Patel D, et al. Disparate effects of obesity and left ventricular geometry on mortality in 8,088 elderly with preserved systolic function. Postgrad Med J. 2009;121:119–125
  48. McAuley P, Myers J, Abella J, Froelicher V. Body mass, fitness and survival in veteran patients: another obesity paradox?. Am J Med. 2007;120:518–524
  49. Jackson AS, Stanforth PR, Gangnon J, et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. Int J Obes Relat Metab Disord. 2002;26:689–796
  50. Wellens RI, Roche AF, Khamis HJ, et al. Relationships between the body mass index and body composition. Obes Res. 1996;4:35–44
  51. Blew RM, Sardinha LB, Milliken LA, et al. Assessing the validity of body mass index standards in early postmenopausal woman. Obes Res. 2002;10:799–808
  52. Lavie CJ, Milani RV, Artham SM, et al. Does body composition impact survival in patients with advanced heart failure. Circulation. 2007;116(16):11–360
  53. Lavie CJ, Milani RV, Ventura HO. Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med. 2008;5(7):428–429
  54. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43(9):1590–1595
  55. Artham SM, Lavie CJ, Patel H, Ventura HO. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometabol Synd. 2008;3:155–161
  56. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metat Disord. 2004;28(Suppl 4):S12–S21
  57. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33(Pt 5):1078–1081
  58. Bays HE, Gonzalez-Campoy JM, Henry RR, et al. Is adiposopathy (“sick fat”) an endocrine disease?. Int J Clin Pract. 2008;10:1474–1483
  59. Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral. Expert Rev Cardiovasc Ther. 2008;3:343–368
  60. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–2556
  61. Sorensen TI. Weight loss causes increased mortality: pros. Obes Rev. 2003;4(1):3–7
  62. Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez FL, et al. Relationship between leptin, C-reactive protein and obesity with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med. 2008;5(7):418–425
  63. Eilat-Adar S, Eldar M, Goldbourt U. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol. 2005;161:352–358
  64. Sierra-Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15:336–340
  65. Osman AF, Mehra MR, Lavie CJ, et al. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000;36:2126–2131

 Funding: None.

 Conflict of Interest: The authors have no conflict of interest regarding this study.

 Authorship: This is an original work and all authors meet the criteria for authorship, including acceptance of responsibility for the scientific content of this manuscript. All authors had access to the data and had roles in writing and revising the manuscript.

PII: S0002-9343(09)00500-2

doi: 10.1016/j.amjmed.2009.06.006

The American Journal of Medicine
Volume 122, Issue 12 , Pages 1106-1114 , December 2009